In melanoma, these signatures were predominantly found in the lymphoid compartment and mainly involved different baseline expression patterns of PD-1 and/or PD-L1: the expression of PD-L1/PD-1 in non-proliferating (Ki67−) CD8+ and CD4+ T cells was associated with worse clinical outcome. Here, CD274 is linked to melanoma.